IRIS
DAMIANI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.972
EU - Europa 3.881
AS - Asia 789
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 12
SA - Sud America 3
OC - Oceania 2
Totale 17.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.871
UA - Ucraina 1.529
DE - Germania 630
CN - Cina 568
FI - Finlandia 494
IT - Italia 409
SE - Svezia 301
IE - Irlanda 240
TR - Turchia 111
FR - Francia 101
CA - Canada 97
GB - Regno Unito 75
IN - India 37
IR - Iran 28
VN - Vietnam 26
RU - Federazione Russa 25
BE - Belgio 17
EU - Europa 13
CZ - Repubblica Ceca 11
TG - Togo 11
NL - Olanda 8
PL - Polonia 8
KR - Corea 7
RO - Romania 6
RS - Serbia 6
BG - Bulgaria 5
CH - Svizzera 4
BR - Brasile 3
JP - Giappone 3
SG - Singapore 3
AT - Austria 2
AU - Australia 2
ES - Italia 2
GL - Groenlandia 2
GR - Grecia 2
HU - Ungheria 2
MX - Messico 2
NO - Norvegia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
LI - Liechtenstein 1
LT - Lituania 1
Totale 17.672
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.113
Ann Arbor 1.688
Fairfield 1.222
Houston 1.176
Jacksonville 1.104
Chandler 762
Dearborn 590
Ashburn 556
Wilmington 505
Seattle 442
Cambridge 374
Beijing 310
Princeton 252
Dublin 239
Izmir 110
Udine 110
San Diego 102
Ottawa 77
Ogden 62
Norwalk 56
Hefei 41
Trieste 39
Des Moines 38
Nanjing 35
Boardman 30
Regensburg 29
Kunming 28
New York 28
Dong Ket 25
Guangzhou 20
Helsinki 20
Simi Valley 19
Augusta 18
Brussels 17
Toronto 17
Jinan 16
Andover 15
Washington 15
Leawood 14
Nanchang 14
Rome 13
Milan 12
San Mateo 12
Fuzhou 11
Lomé 11
Monmouth Junction 11
Grafing 9
Phoenix 9
Zanjan 9
Duino-Aurisina 8
Hebei 8
Mumbai 8
Warsaw 8
Wuhan 8
Ardabil 7
Brno 7
Belgrade 6
Horia 6
Redwood City 6
Saint Petersburg 6
Shenyang 6
Ningbo 5
Redmond 5
Sofia 5
Caserta 4
Edinburgh 4
Hangzhou 4
Napoli 4
Zhengzhou 4
Altopascio 3
Arba 3
Bangalore 3
Baotou 3
Changsha 3
Chengdu 3
Florence 3
Frankfurt am Main 3
Lanzhou 3
London 3
New Delhi 3
Prague 3
Sacramento 3
Shaoxing 3
Tokyo 3
Torino 3
Venezia 3
Xian 3
Zero Branco 3
Zurich 3
Acerra 2
Athens 2
Barletta 2
Budapest 2
Chaoyang 2
Corleto Perticara 2
Gemona 2
Harbin 2
Henderson 2
Huzhou 2
Indiana 2
Totale 12.626
Salva come PNG Salva come JPEG
Nome #
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy 232
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 170
“Fibre nervose peptidergiche intraepidermiche: uno studio immunoistochimico”. 151
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non MDR cells to different anthracycline derivatives 143
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 135
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 127
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 126
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells 125
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 124
Histone post-translational modifications associated to BAALC expression in leukemic cells. 118
Clinical feature and outcome in seven patients wuth hyaline or mixed variant of Castleman’s disease. A single centre experience 117
“Overexpression of multidrug resistance-associated P-170 glycoprotein in acute non lymphocytic leukemia”. 117
Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-hematologic diseases. 115
Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome. 113
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 113
Granulocyte-macrophage colony -stimulating factor in acute nonlymphocytic leukemia before and after chemo therapy”. 112
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 112
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. 112
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 111
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission 111
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 110
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia 110
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 108
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. 107
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias 107
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 104
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia 104
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 104
“Case report: mdr-1 gene amplification in acute lymphoblastic leukemia prior to antileukemic treatment”. 104
“Long Term Follow-up of the Italian Trial of Interferon-a Versus Conventional Chemotherapy in Chronic Myeloid Leukemia”. 103
Visualization of PGP 9.5 immunoreactive nerve terminals in the mouse snout epidermis. 103
“D-Verapamil downmodulates P-170 associated resistance to doxorubicin, daunorubicin and idarubicin”. 102
CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis”. 102
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome 102
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement 102
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia. 102
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 101
Unexpected phenotype of a typical NPM1 mutant 100
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 100
Multipotent Mesenchymal Stem Cells Can Be Isolated and Grown from Many Tissues (Bone Marrow, Liver and Heart) 100
“Espressione dell’antigene CD34 nei tessuti normali e patologici e possibili applicazioni cliniche delle cellule CD34”. 99
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera. 99
Flow cytometry evaluation of plasma cells contaminating leukapheresis pre- and post- CD34-positive selection- 97
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 97
FEASIBILITY OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH CD34 SELECTED STEM CELLS: OUTCOME AND IMMUNOLOGICAL COMPLICATIONS 96
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 96
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia 96
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML 95
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 94
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 94
“Expression of Multidrug resistance gene (MDR 1) in normal hematopoietic cells”. 93
Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression 93
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 92
Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. 92
Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells. 91
Dendritic cell recovery after autologous stem cell transplantation 91
Peripheral blood stem cell mobilization in multiple myeloma: advantage of 7 vs. 4 g/m2 cyclophosfamide on stem cell quality and plasma cell mobilization. 90
Cytokines dysregulation and chronic graft versus host disease after allogeneic haematopoieitc stem cell transplantation with reduced intensity conditioning 90
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 90
Suggestive evidence for a Microanatomical Relationship betweeb Mast Cells and Nerve Fibres Containing Substance P, Calcitonin Gene Related Peptide, Vasoactive Intestinal Polypeptide, and Somatostatin in the rat Mesentery. 90
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 90
Acute promyelocytic leucemia: low expression of multidrug resistance phenotype at onset suggest a favourable effect of gentuzumab ozogamicyn (CMA-676 88
Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis 88
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 88
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 87
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 87
“Treatment of Ph+ chronic myeloid leukemia by gamma interferon”. 86
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 years treated with induction regimens including fludarabine: retrospective analysis of 224 cases 86
“Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas”. 86
KIR POLYMORPHISM IN REDUCED INTENSITY HLA-ID SIBLING STEM CELL TRANSPLANTATION: IMPACT ON CLINICAL OUTCOME 86
5-AZACITIDINE FIVE DAYS/MONTHLY SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC (MDS) PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS Authors 86
Proliferation and maturation effects of in vivo granulo-monocyte colony stimulating factor in acute non-lymphocytic leucemia”. 85
DENDRITIC CELL RECOVERY AFTER AUTOLOGOUS AND ALLOGENEIC TRANSPLANTATION 84
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation 84
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. 84
Serotoninergic fibres form dense synaptic contacts with Purkinje cells in the mouse cerebellar cortex--an immunohistochemical study 84
Isolation, characterization and in vitro growth of human multipotent adult cardiac progenitor cells 83
Acute promyelocyttic leucemia: low expression of multidrug resistance phenotype at onset suggests a favorable effect of Gemtuzumab Ozogamycin (CMA 676) 82
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) in de novo adult acute lymphoblastica leukemia 82
The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia. 80
Fludarabine, Arabynosil cytosine and Idarubicin (FLAI), a combination of non MDR related drugs for tratment of patients with newly diagnosed acute myeloi leukemia. 80
A study of the material in the ATLAS inner detector using secondary hadronic interactions 80
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia. 79
Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia 79
Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies. 79
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias 78
“The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkins’ Lymphoma patients” 78
Sequential study of cytokine and lymphocyte patterns in patients with chronic agraft versus host disease after reduced intensity conditioning allogenic stem cell transplantation 78
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 78
“Multidrug resistance (MDR1) in acute myelogenous leukemia: is it time to test?” 77
Treatment intensification of malignant lymphomas with autologous bone marrow transplantation and granulocyte colony stimulating factor. 77
A mutational status of IGVH genes consisten with antigen-driven selection has prognostic impact istead of percento f mutations in B-cell chronic lymphocytic leukemia 77
Efficacy of tuemor necrosis factor alfa blockade with infliximab for the treatment of svere steroid-refractory acute graft versus host disease. 77
FEASIBILITY AND OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS WITH POOR RISK ACUTE MYELOID LEUKEMIA 77
Invasive fungal infections in allogneic haematopoietic stem cell transplantation: 12 years experience on 246 patients at a single institution 76
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients 76
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. 75
A simple Prognostic Scoring System for newly diagnosed acute leukaemia patients with normal karyotype: a retrospective analysis on 173 cases. 75
Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. 75
Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia. 75
Totale 9.786
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019943 0 0 0 0 0 0 0 0 0 171 480 292
2019/20204.536 239 276 169 591 290 791 460 529 264 443 116 368
2020/20212.774 44 309 21 364 71 404 154 343 493 68 414 89
2021/20221.898 53 276 69 167 64 47 78 103 19 311 396 315
2022/20231.861 273 97 16 226 188 519 6 149 254 31 57 45
2023/2024526 98 58 35 27 71 84 10 33 86 24 0 0
Totale 18.002